New American Medical Association Psychedelic Therapy Codes Take Effect As FDA Weighs Prescription MDMA Application

As the Food and Drug Administration (FDA) considers an application to approve MDMA as a prescription drug, new standards from the American Medical Association (AMA) have officially taken effect that assign psychedelics-specific codes to collect data on the novel therapies. AMA approved Current Procedural Terminology (CPT) III codes for psychedelic medicines in July after collaborating … Continue reading New American Medical Association Psychedelic Therapy Codes Take Effect As FDA Weighs Prescription MDMA Application